Literature DB >> 20097285

Increased SOD1 association with chromatin, DNA damage, p53 activation, and apoptosis in a cellular model of SOD1-linked ALS.

Livea F Barbosa1, Fernanda M Cerqueira, Antero F A Macedo, Camila C M Garcia, José Pedro F Angeli, Robert I Schumacher, Mari Cleide Sogayar, Ohara Augusto, Maria Teresa Carrì, Paolo Di Mascio, Marisa H G Medeiros.   

Abstract

Mutations in the gene encoding cytosolic Cu,Zn-superoxide dismutase (SOD1) have been linked to familial amyotrophic lateral sclerosis (FALS). However the molecular mechanisms of motor neuron death are multi-factorial and remain unclear. Here we examined DNA damage, p53 activity and apoptosis in SH-SY5Y human neuroblastoma cells transfected to achieve low-level expression of either wild-type or mutant Gly(93)-->Ala (G93A) SOD1, typical of FALS. DNA damage was investigated by evaluating the levels of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo) and DNA strand breaks. Significantly higher levels of DNA damage, increased p53 activity, and a greater percentage of apoptotic cells were observed in SH-SY5Y cells transfected with G93A SOD1 when compared to cells overexpressing wild-type SOD1 and untransfected cells. Western blot, FACS, and confocal microscopy analysis demonstrated that G93A SOD1 is present in the nucleus in association with DNA. Nuclear G93A SOD1 has identical superoxide dismutase activity but displays increased peroxidase activity when compared to wild-type SOD1. These results indicate that the G93A mutant SOD1 association with DNA might induce DNA damage and trigger the apoptotic response by activating p53. This toxic activity of mutant SOD1 in the nucleus may play an important role in the complex mechanisms associated with motor neuron death observed in ALS pathogenesis. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097285     DOI: 10.1016/j.bbadis.2010.01.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

Review 1.  Acetyltransferases (HATs) as targets for neurological therapeutics.

Authors:  Anne Schneider; Snehajyoti Chatterjee; Olivier Bousiges; B Ruthrotha Selvi; Amrutha Swaminathan; Raphaelle Cassel; Frédéric Blanc; Tapas K Kundu; Anne-Laurence Boutillier
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 2.  Synthetic combinations of missense polymorphic genetic changes underlying Down syndrome susceptibility.

Authors:  Rebecca A Jackson; Mai Linh Nguyen; Angela N Barrett; Yuan Yee Tan; Mahesh A Choolani; Ee Sin Chen
Journal:  Cell Mol Life Sci       Date:  2016-05-31       Impact factor: 9.261

3.  Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.

Authors:  Barry Gertz; Margaret Wong; Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

4.  Dietary lipid unsaturation influences survival and oxidative modifications of an amyotrophic lateral sclerosis model in a gender-specific manner.

Authors:  Daniel Cacabelos; Victoria Ayala; Omar Ramírez-Nunez; Ana Belen Granado-Serrano; Jordi Boada; Jose C E Serrano; Rosanna Cabré; Gisela Nadal-Rey; Maria Josep Bellmunt; Isidro Ferrer; Reinald Pamplona; Manuel Portero-Otin
Journal:  Neuromolecular Med       Date:  2014-07-01       Impact factor: 3.843

5.  Amyotrophic lateral sclerosis: update and new developments.

Authors:  Ashley J Pratt; Elizabeth D Getzoff; J Jefferson P Perry
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-02

Review 6.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

7.  DNA-triggered aggregation of copper, zinc superoxide dismutase in the presence of ascorbate.

Authors:  Jun Yin; Si Hu; Wei Jiang; Liang Liu; Shemin Lan; Xuegang Song; Changlin Liu
Journal:  PLoS One       Date:  2010-08-20       Impact factor: 3.240

8.  Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis.

Authors:  Joanna Iłżecka
Journal:  Neurol Sci       Date:  2011-11-03       Impact factor: 3.307

Review 9.  DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity.

Authors:  Jannigje Rachel Kok; Nelma M Palminha; Cleide Dos Santos Souza; Sherif F El-Khamisy; Laura Ferraiuolo
Journal:  Cell Mol Life Sci       Date:  2021-06-26       Impact factor: 9.261

10.  Tempol moderately extends survival in a hSOD1(G93A) ALS rat model by inhibiting neuronal cell loss, oxidative damage and levels of non-native hSOD1(G93A) forms.

Authors:  Edlaine Linares; Luciana V Seixas; Janaina N dos Prazeres; Fernando V L Ladd; Aliny A B L Ladd; Antonio A Coppi; Ohara Augusto
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.